A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
Francesco Passamonti(University of Milan), Ayalew Tefferi(Mayo Clinic), Irene Bertozzi(University of Padua), Alessandra Carobbio(Ospedale Papa Giovanni XXIII), Valentina Carrai(University of Bergamo), François Girodon(Inserm), Domenica Caramazza(Ospedale di Circolo e Fondazione Macchi), Emanuele S. G. d'Amore(Ospedale San Bortolo), Emanuela Boveri(Policlinico San Matteo Fondazione), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Maria Luigia Randi(University of Padua), Heinz Gisslinger(Medical University of Vienna), Mario Cazzola(Roche (Switzerland)), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Hans Michael Kvasnicka(Helios Universitätsklinikum Wuppertal), Andrea Gianatti(University of Bergamo), Cristiana Pascutto(University of Pavia), Tiziano Barbui(University of Bergamo), Elisa Rumi(University of Pavia), Elisabetta Antonioli(Azienda Ospedaliero-Universitaria Careggi), Bettina Gisslinger(Medical University of Vienna), Marco Ruggeri(Ospedale San Bortolo), Margherita Maffioli, Curtis A. Hanson(Toyota Motor Corporation (Switzerland)), Filippo Marino(University of Padua), Jürgen Thiele, Leonhard Müllauer(Hochschule Campus Wien), Francesco Rodeghiero(Ospedale San Bortolo), Naseema Gangat(Mayo Clinic in Arizona)
Cited by 270
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k